Jonae R. Barnes
Investor Relations Kontakt bei ATEA PHARMACEUTICALS, INC.
Aktive Positionen von Jonae R. Barnes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ATEA PHARMACEUTICALS, INC. | Investor Relations Kontakt | 19.01.2021 | - |
Public Communications Contact | 19.01.2021 | - |
Karriereverlauf von Jonae R. Barnes
Ehemalige bekannte Positionen von Jonae R. Barnes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Investor Relations Kontakt | 01.01.2007 | 01.12.2009 |
Public Communications Contact | 01.01.2007 | 01.12.2009 | |
POXEL | Investor Relations Kontakt | 14.03.2016 | - |
Public Communications Contact | 14.03.2016 | - | |
AGENUS INC. | Investor Relations Kontakt | 01.01.2011 | - |
IDENIX PHARMACEUTICALS INC | Investor Relations Kontakt | - | - |
Public Communications Contact | 29.10.2010 | - |
Ausbildung von Jonae R. Barnes
Suffolk University | Undergraduate Degree |
Boston University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Frankreich | 2 |
Operativ
Investor Relations Contact | 5 |
Public Communications Contact | 4 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
AGENUS INC. | Health Technology |
POXEL | Health Technology |
ATEA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Jonae R. Barnes
- Erfahrung